Leo Grady, the former CEO of Paige AI – developers of the first AI-based histology software to be granted approval by the US Food and Drug Administration – has turned his attention to the gut health space.
In the two years since his departure from Paige, Grady has been working, under
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?